Your session is about to expire
← Back to Search
Methazolamide 25 mg for Open-Angle Glaucoma
Study Summary
This trial is testing whether methazolamide can safely and effectively lower intraocular pressure.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Does this research encompass those aged 65 and above?
"As specified in the admission criteria, participants must be within a 50 to 90 years old age range."
Is Methazolamide 25 mg a safe dosage to take on an ongoing basis?
"The safety of Methazolamide 25 mg was classified as a 3 due to the Phase 4 trial status and its existing approval."
What is the current status of recruitment for this clinical trial?
"As detailed on clinicaltrials.gov, this particular study is not actively searching for participants at the moment - though it was initially posted on August 15th 2022 and last modified two days later. On the bright side, there are presently 216 other trials that could use more volunteers."
What objectives is this research endeavor aiming to satisfy?
"The primary evaluation of this clinical trial, which will take place over the course of Day 1 (Pre-dosing, then 4- and 8- hours post dosing), Day 7 (Pre-dosing, then 4- and 8- hours post dosing), Day 14 (Pre-dosing, then 4"
Who qualifies to be a participant in this research program?
"In order to qualify for this glaucoma clinical trial, applicants must be between the ages of 50 and 90 and have an open-angle diagnosis. This medical investigation is currently in need of 30 participants."
Share this study with friends
Copy Link
Messenger